Hikma Pharmaceuticals (LSE:HIK) Inventories, Raw Materials & Components : £397 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Hikma Pharmaceuticals Inventories, Raw Materials & Components?

Hikma Pharmaceuticals's inventories, raw materials & components for the quarter that ended in Dec. 2023 was £397 Mil.

Hikma Pharmaceuticals's quarterly raw materials increased from Dec. 2022 (£373 Mil) to Jun. 2023 (£416 Mil) but then declined from Jun. 2023 (£416 Mil) to Dec. 2023 (£397 Mil).

Hikma Pharmaceuticals's annual raw materials increased from Dec. 2021 (£309 Mil) to Dec. 2022 (£373 Mil) and increased from Dec. 2022 (£373 Mil) to Dec. 2023 (£397 Mil).

Hikma Pharmaceuticals Inventories, Raw Materials & Components Historical Data

The historical data trend for Hikma Pharmaceuticals's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikma Pharmaceuticals Inventories, Raw Materials & Components Chart

Hikma Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Raw Materials & Components

Get a 7-Day Free Trial

235.00

317.69

309.07

372.73

396.58

Hikma Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Inventories, Raw Materials & Components	Get a 7-Day Free Trial															309.07	-	372.73	415.80	396.58

Hikma Pharmaceuticals Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Hikma Pharmaceuticals (LSE:HIK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (LSE:HIK) » Definitions » Inventories, Raw Materials & Components

Comparable Companies

Traded in Other Exchanges

HKMPY:USA HKMPF:USA HIKl:UK H5P:Germany

Address

1 New Burlington Place, London, GBR, W1S 2HR

Website

https://www.hikma.com

Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.

Hikma Pharmaceuticals (LSE:HIK) Headlines

No Headlines